Longevity News

Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis

Source: PR Newswire • Published: 24 Jul 2026, 12:30

Roche receives FDA clearance for the cobas® BV/CV assay, enabling fast and highly accurate vaginitis diagnosis

A news article about a newly cleared lab molecular test for diagnosing common causes of vaginitis, and what reading it offers clinicians and labs.

Key Takeaways
  • It enables accurate and timely results that can lead to improved patient outcomes and enhanced healthcare efficiencies
  • Vaginitis is one of the most common reasons women visit a healthcare provider
  • 3 Clinicians have traditionally relied on less precise methods such as microscopy
Read Original Source